Xtl Biopharmaceuticals (XTLB) Return on Equity [ROE] (2009 - 2024)
Xtl Biopharmaceuticals (XTLB) posted Return on Equity [ROE] of -269.02% for the year ended Dec 31, 2025, down 242.19 percentage points from -26.83% a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Return on Equity [ROE] (2009 - 2024) Analysis & Trends
Since the year ended Dec 31, 2009, Xtl Biopharmaceuticals has reported Return on Equity [ROE] for 17 years.
- Annual Return on Equity [ROE] shows a five-year change of -210.68 percentage points (years ended Dec 2020 to Dec 2025).
- The figure for the year ended Dec 31, 2025 stands as the lowest annual Return on Equity [ROE] in data going back to the year ended Dec 31, 2009.
- Business Quant data shows XTLB's Return on Equity [ROE] at -26.83% in the year ended Dec 31, 2024 (+30.48 pp), -57.31% in the year ended Dec 31, 2023 (-28.42 pp), -28.89% in the year ended Dec 31, 2022 (-38.62 pp) and 9.73% in the year ended Dec 31, 2021 (+68.07 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Xtl Biopharmaceuticals | 2.03 Bn | 2.03 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -25.18% |
| Sep 30, 2024 | -36.05% |
| Jun 30, 2024 | -44.35% |
| Mar 31, 2024 | -33.99% |
| Dec 31, 2023 | -38.68% |
| Sep 30, 2023 | -52.77% |
| Jun 30, 2023 | -68.39% |
| Mar 31, 2023 | -59.46% |
| Dec 31, 2022 | -48.11% |
| Sep 30, 2022 | -31.84% |
| Jun 30, 2022 | -18.06% |
| Mar 31, 2022 | -33.91% |
| Dec 31, 2021 | -39.13% |
| Sep 30, 2021 | -42.76% |
| Jun 30, 2021 | -30.07% |
| Mar 31, 2021 | -27.70% |
| Dec 31, 2020 | -22.93% |
| Sep 30, 2020 | -42.19% |
| Jun 30, 2020 | -39.87% |
| Mar 31, 2020 | -20.38% |
API Access
Xtl Biopharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();